Engineering immunosuppressive drug-resistant armored (IDRA) SARS-CoV-2 T cells for cell therapy.
Chen Q, Chia A, Hang SK, Lim A, Koh WK, Peng Y, Gao F, Chen J, Ho Z, Wai LE, Kunasegaran K, Tan AT, Le Bert N, Loh CY, Goh YS, Renia L, Dong T, Vathsala A, Bertoletti A.
Chen Q, et al.
Cell Mol Immunol. 2023 Nov;20(11):1300-1312. doi: 10.1038/s41423-023-01080-3. Epub 2023 Sep 5.
Cell Mol Immunol. 2023.
PMID: 37666955
Free PMC article.